在美国，多西环素用于女性出生人群的性传播感染暴露后预防。

IF 1.7 4区医学 Q3 INFECTIOUS DISEASES

Sexually transmitted diseases Pub Date : 2025-07-01 DOI:10.1097/OLQ.0000000000002215

Aniruddha Hazra, Chase Cannon, Jason Bena, Oliver Bacon, Jason Lee, Hyman Scott, Stephanie E Cohen

{"title":"在美国，多西环素用于女性出生人群的性传播感染暴露后预防。","authors":"Aniruddha Hazra, Chase Cannon, Jason Bena, Oliver Bacon, Jason Lee, Hyman Scott, Stephanie E Cohen","doi":"10.1097/OLQ.0000000000002215","DOIUrl":null,"url":null,"abstract":"Abstract: This multi-center case series examines real-world use of doxycycline post-exposure prophylaxis (doxy-PEP) among persons assigned female at birth (AFAB) at four U.S. sexual health clinics. Most cases were transgender men highly vulnerable to STI acquisition. Findings highlight early implementation patterns, safety considerations, and underscore the urgent need for doxy-PEP efficacy data in AFAB populations.","PeriodicalId":21837,"journal":{"name":"Sexually transmitted diseases","volume":" ","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Use of Doxycycline for STI Post-Exposure Prophylaxis in People Assigned Female at Birth in the United States.\",\"authors\":\"Aniruddha Hazra, Chase Cannon, Jason Bena, Oliver Bacon, Jason Lee, Hyman Scott, Stephanie E Cohen\",\"doi\":\"10.1097/OLQ.0000000000002215\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract: This multi-center case series examines real-world use of doxycycline post-exposure prophylaxis (doxy-PEP) among persons assigned female at birth (AFAB) at four U.S. sexual health clinics. Most cases were transgender men highly vulnerable to STI acquisition. Findings highlight early implementation patterns, safety considerations, and underscore the urgent need for doxy-PEP efficacy data in AFAB populations.\",\"PeriodicalId\":21837,\"journal\":{\"name\":\"Sexually transmitted diseases\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Sexually transmitted diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/OLQ.0000000000002215\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sexually transmitted diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/OLQ.0000000000002215","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

摘要

摘要：本多中心病例系列研究了在美国四家性健康诊所出生时被指定为女性的人（AFAB）中多西环素暴露后预防（doxy-PEP）的实际使用情况。大多数病例是易受性传播感染的跨性别男性。研究结果强调了早期实施模式、安全性考虑，并强调了迫切需要在AFAB人群中获得doxy-PEP疗效数据。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Use of Doxycycline for STI Post-Exposure Prophylaxis in People Assigned Female at Birth in the United States.

Abstract: This multi-center case series examines real-world use of doxycycline post-exposure prophylaxis (doxy-PEP) among persons assigned female at birth (AFAB) at four U.S. sexual health clinics. Most cases were transgender men highly vulnerable to STI acquisition. Findings highlight early implementation patterns, safety considerations, and underscore the urgent need for doxy-PEP efficacy data in AFAB populations.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Sexually transmitted diseases 医学-传染病学

CiteScore

4.00

自引率

16.10%

发文量

289

审稿时长

3-8 weeks

期刊介绍： Sexually Transmitted Diseases, the official journal of the American Sexually Transmitted Diseases Association, publishes peer-reviewed, original articles on clinical, laboratory, immunologic, epidemiologic, behavioral, public health, and historical topics pertaining to sexually transmitted diseases and related fields. Reports from the CDC and NIH provide up-to-the-minute information. A highly respected editorial board is composed of prominent scientists who are leaders in this rapidly changing field. Included in each issue are studies and developments from around the world.